Skip to content

Drug interactions

Daunorubicin + Nicardipine

Severity: Moderate

Daunorubicin and Nicardipine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nicardipine can inhibit P-glycoprotein and may raise intracellular and systemic exposure to daunorubicin. This could in theory increase myelosuppression and cardiotoxicity, although the clinical significance is not well established.

What this interaction means in plain words

Daunorubicin and Nicardipine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Daunorubicin belongs to Oncology; Nicardipine belongs to Cardiovascular.

Evidence level: Low

Why it happens

Inhibition of P-glycoprotein efflux of daunorubicin by nicardipine.

What to do

Monitor blood counts and cardiac function during concurrent use. Be alert for enhanced anthracycline toxicity.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Daunorubicin and Nicardipine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Daunorubicin with Nicardipine?

MediHelp rates the interaction as moderate. Daunorubicin and Nicardipine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Nicardipine can inhibit P-glycoprotein and may raise intracellular and systemic exposure to daunorubicin. This could in theory increase myelosuppression and cardiotoxicity, although the clinical significance is not well established.

How serious is the interaction between Daunorubicin and Nicardipine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and cardiac function during concurrent use. Be alert for enhanced anthracycline toxicity.

What other medicines interact with Nicardipine?

MediHelp also lists interactions of Nicardipine with, for example, Amifostine, Amlodipine-olmesartan-hydrochlorothiazide, Betrixaban. The full list is on the Nicardipine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in